557 related articles for article (PubMed ID: 23464866)
1. Serum IL-33 levels and skin mRNA expression in Behçet's disease.
Hamzaoui K; Kaabachi W; Fazaa B; Zakraoui L; Mili-Boussen I; Haj-Sassi F
Clin Exp Rheumatol; 2013; 31(3 Suppl 77):6-14. PubMed ID: 23464866
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-37 expression is decreased in Behçet's disease and is associated with inflammation.
Bouali E; Kaabachi W; Hamzaoui A; Hamzaoui K
Immunol Lett; 2015 Oct; 167(2):87-94. PubMed ID: 26253248
[TBL] [Abstract][Full Text] [Related]
3. Up-regulation of Th17 and related cytokines in Behçet's disease corresponding to disease activity.
Na SY; Park MJ; Park S; Lee ES
Clin Exp Rheumatol; 2013; 31(3 Suppl 77):32-40. PubMed ID: 24064012
[TBL] [Abstract][Full Text] [Related]
4. Increased serum interleukin-32 levels in patients with Behçet's disease.
Ha YJ; Park JS; Kang MI; Lee SK; Park YB; Lee SW
Int J Rheum Dis; 2018 Dec; 21(12):2167-2174. PubMed ID: 28378461
[TBL] [Abstract][Full Text] [Related]
5. Serum BAFF levels and skin mRNA expression in patients with Behçet's disease.
Hamzaoui K; Houman H; Ben Dhifallah I; Kamoun M; Hamzaoui A
Clin Exp Rheumatol; 2008; 26(4 Suppl 50):S64-71. PubMed ID: 19026118
[TBL] [Abstract][Full Text] [Related]
6. Higher expression of Toll-like receptors 2, 3, 4, and 8 in ocular Behcet's disease.
Liu X; Wang C; Ye Z; Kijlstra A; Yang P
Invest Ophthalmol Vis Sci; 2013 Sep; 54(9):6012-7. PubMed ID: 23908180
[TBL] [Abstract][Full Text] [Related]
7. Serum Interleukin-33 in Behcet's Disease: Its Relation to Disease Activity and Clinical Manifestations.
Fawzy RM; Said EA; Mohamed SM; Fouad NA; Akl EM
Egypt J Immunol; 2015 Jun; 22(2):1-8. PubMed ID: 28502139
[TBL] [Abstract][Full Text] [Related]
8. Investigating the role of IL-33 in the pathogenesis of Behçet's Disease.
Çerçi P; Altıner S; İnal A; Köse K; Keskin G; Ölmez Ü
Acta Clin Belg; 2017 Dec; 72(6):434-438. PubMed ID: 28412856
[TBL] [Abstract][Full Text] [Related]
9. Skewed TGFβ/Smad signalling pathway in T cells in patients with Behçet's disease.
Shimizu J; Izumi T; Arimitsu N; Fujiwara N; Ueda Y; Wakisaka S; Yoshikawa H; Kaneko F; Suzuki T; Takai K; Suzuki N
Clin Exp Rheumatol; 2012; 30(3 Suppl 72):S35-9. PubMed ID: 22935165
[TBL] [Abstract][Full Text] [Related]
10. Elevated levels of interleukin-27 and effect on production of interferon-γ and interleukin-17 in patients with Behçet's disease.
Shen H; Xia LP; Lu J
Scand J Rheumatol; 2013; 42(1):48-51. PubMed ID: 23101722
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D modulates peripheral immunity in patients with Behçet's disease.
Hamzaoui K; Ben Dhifallah I; Karray E; Sassi FH; Hamzaoui A
Clin Exp Rheumatol; 2010; 28(4 Suppl 60):S50-7. PubMed ID: 20868571
[TBL] [Abstract][Full Text] [Related]
12. Altered expression of costimulatory molecules in Behçet's disease according to clinical activity.
Sim JH; Park MJ; Park S; Lee ES
Br J Dermatol; 2011 Jun; 164(6):1285-91. PubMed ID: 21574973
[TBL] [Abstract][Full Text] [Related]
13. Serum levels of TNF-alpha, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Behçet's disease.
Evereklioglu C; Er H; Türköz Y; Cekmen M
Mediators Inflamm; 2002 Apr; 11(2):87-93. PubMed ID: 12061429
[TBL] [Abstract][Full Text] [Related]
14. Behçet's disease heterogeneity: cytokine production and oxidative burst of phagocytes are altered in patients with severe manifestations.
Perazzio SF; Soeiro-Pereira PV; de Souza AW; Condino-Neto A; Andrade LE
Clin Exp Rheumatol; 2015; 33(6 Suppl 94):S85-95. PubMed ID: 26394190
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-28A promotes IFN-γ production by peripheral blood mononuclear cells from patients with Behçet's disease.
Li B; Xie C; Lin X; Su SB
Cell Immunol; 2014 Jul; 290(1):116-9. PubMed ID: 24973639
[TBL] [Abstract][Full Text] [Related]
16. Association of Reduced Heme Oxygenase-1 with Decreased MicroRNA-196a2 Expression in Peripheral Blood Mononuclear Cells of Patients with Intestinal Behcet's Disease.
Zou J; Ji DN; Shen Y; Guan JL; Zheng SB
Ann Clin Lab Sci; 2016 Dec; 46(6):675-679. PubMed ID: 27993883
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-23 Receptor Gene Polymorphism May Enhance Expression of the IL-23 Receptor, IL-17, TNF-α and IL-6 in Behcet's Disease.
Jiang Z; Hennein L; Tao Y; Tao L
PLoS One; 2015; 10(7):e0134632. PubMed ID: 26222305
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-26 is overexpressed in Behçet's disease and enhances Th17 related -cytokines.
Kaabachi W; Bouali E; Berraïes A; Dhifallh IB; Hamdi B; Hamzaoui K; Hamzaoui A
Immunol Lett; 2017 Oct; 190():177-184. PubMed ID: 28811236
[TBL] [Abstract][Full Text] [Related]
19. Expression of Th-17 and RORγt mRNA in Behçet's Disease.
Hamzaoui K; Bouali E; Ghorbel I; Khanfir M; Houman H; Hamzaoui A
Med Sci Monit; 2011 Apr; 17(4):CR227-34. PubMed ID: 21455110
[TBL] [Abstract][Full Text] [Related]
20. Upregulated IL-23 and IL-17 in Behçet patients with active uveitis.
Chi W; Zhu X; Yang P; Liu X; Lin X; Zhou H; Huang X; Kijlstra A
Invest Ophthalmol Vis Sci; 2008 Jul; 49(7):3058-64. PubMed ID: 18579762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]